A carregar...
Inhibiting DosRST as a new approach to tuberculosis therapy
Progress against tuberculosis (TB) requires faster-acting drugs. Mycobacterium tuberculosis (Mtb) is the leading cause of death by an infectious disease and its treatment is challenging and lengthy. Mtb is remarkably successful, in part, due to its ability to become dormant in response to host immun...
Na minha lista:
| Publicado no: | Future Med Chem |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Newlands Press Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7607383/ https://ncbi.nlm.nih.gov/pubmed/32053005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2019-0263 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|